GatekeeperpHarmA.com
About GatekeeperpHarmA.com
GATEKEEPER Pharmaceuticals is focused on developing next generation small molecule drugs that overcome resistance arising from treatment by targeted oncology agents. GATEKEEPER's lead product is a proprietary EGFR inhibitor that potently overcomes resistance to Tarceva® and Iressa® treatment. For further information, please inquire at info[at]gatekeeperpharma.com.